Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a δ- and κ-opioid receptor agonist

Life Sciences

Volumn 75, Issue 5, 2004, Pages 559-573

  Picolo, Gisele ^a   Cury, Yara ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Analgesia; cGMP dependent protein kinase; Crotalus durissus terrificus venom; L arginine NO cGMP pathway; Neuronal nitric oxide (NO) synthase; Opioid receptors

Indexed keywords

1H (1,2,4)OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 7 NITROINDAZOLE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; GUANYLATE CYCLASE INHIBITOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROTALUS DURISSUS TERRIFICUS; DATA ANALYSIS; HYPERALGESIA; INHIBITION KINETICS; MALE; NONHUMAN; RAT; SNAKE;

CROTALUS; CROTALUS DURISSUS TERRIFICUS; SERPENTES;

EID: 2442639985     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.12.024     Document Type: Article

References (53)

1. Amarante L.H., Duarte I.D. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/ nitric oxide/ cyclic GMP pathway. European Journal of Pharmacology. 454:2002;19-23
2. Antonijevic I., Mousa S.A., Schäfer M., Stein C. Perineural defect and peripheral opioid analgesia in inflammation. Journal of Neuroscience. 15:1995;165-172
3. Brazil V., Pestana B.R. Nova contribuição ao estudo do envenenamento ophídico. Revista Médica de São Paulo. 12:1909;415-425
4. Brigatte P., Hoffmann F.A., Bernardi M.M., Giorgi R., Fernandes I., Takehara H.A., Barros S.B.M., Almeida M.G., Cury Y. Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediate by pharmacodynamic mechanisms. Toxicon. 39:2001;1399-1410
5. Cahill C.M., Morinville A., Hoffert C., O'Donnell D., Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain. 101:2003;199-208
6. Cunha F.Q., Lorenzetti B.B., Poole S., Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. British Journal of Pharmacology. 104:1991;765-767
7. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia. British Journal of Pharmacology. 107:1992;660-664
8. Dray A. Inflammatory mediators of pain. British Journal of Anaesthesia. 75:1995;125-131
9. Dillen L., Miserez B., Claeys M., Aunis D., De Potter W. Posttranslational processing of proenkephalins and chromogranins/secretogranins. Neurochemistry International. 22:1993;315-352
10. Duarte I.D.G., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. European Journal of Pharmacology. 186:1990;289-293
11. Ferreira S.H. Local control of inflammatory pain. Russo-Marie F., Vargaftig B.B., Benveniste J. Pharmacology of Inflammation and Allergy. vol. 100:1981;349-356 INSERM, Paris
12. Ferreira S.H. Site of analgesic action of aspirin-like drugs and opioids. Beers R.F., Bassett E.G. Mechanisms of pain and analgesic compounds. 1979;309-321 Raven Press, New York
13. Ferreira S.H., Duarte I.D.G., Lorenzetti B.B. Molecular base of acetylcholine and morphine analgesia. Drug in inflammation. 1991;101-106 Birkhäuser Verlag, Basel
14. Ferreira S.H., Duarte I.D.G., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of cGMP system via nitric oxide release. European Journal of Pharmacology. 1217:1991;225-227
15. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin - 1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 334:1988;698-700
16. Ferreira S.H., Lorenzetti B.B., Correa F.M.A. Central and peripheral antialgesics action of aspirin-like drug. European Journal of Pharmacology. 53:1978;39-48
17. Ferreira S.H., Lorenzetti B.B., Pool S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. British Journal of Pharmacology. 110:1993;1227-1231
18. Ferreira S.H., Nakamura M. Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins. 18:1979;191-200
19. Ferreira S.H., Nakamura M. II Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid antagonists. Prostaglandins. 18:1979;201-208
20. Gad S.C., Weil C.S. Statistics for toxicologists. Hayer A.W. Principles and Methods of Toxicology. 2nd ed. 1989;435-483 Raven Press, New York
21. Giorgi R., Bernardi M.M., Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon. 31:1993;1257-1265
22. Granados-Soto V., Rufino M.O., Lopes L.D.G., Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. European Journal of Pharmacology. 340:1997;177-180
23. Handy R.L., Moore P.K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. British Journal of Pharmacology. 123:1998;1119-1126
24. Hao J.X., Xu X.J. Treatment of a chronic allodynia-like response in spinally injured rats: effect of systemically administered nitric oxide synthase inhibitors. Pain. 66:1996;313-319
25. Hassan A.H.S., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55:1993;185-195
26. Hingtgen C.M., Waite K.J., Vasko M.R. Prostaglandins facilitate peptide release from rat sensory neurons by activating the cAMP transduction cascade. Journal of Neuroscience. 15:1995;5411-5419
27. Kayser V., Chen Y.L., Guilbauld G. Behavioral evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in carrageenin-induced hyperalgesia rats. Brain Research. 560:1991;237-244
28. + channel pathway in the antinociceptive action of ketorolac. European Journal of Pharmacology. 426:2001;39-44
29. Lorenzetti B.B., Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflammation Research. 45:1996;308-311
30. Meller S.T., Gebhart G.F. Nitric Oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136
31. Millan M.J. Multiple opioid systems and pain. Pain. 27:1986;303-347
32. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. British Journal of Pharmacology. 108:1993;296-297
33. Moore W.M., Webber R.K., Jerome J.M., Tjoeng F.S., Misko T.P., Currie M.G. L-N6-(1-Iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. Journal of Medicinal Chemistry. 37:1994;3886-3888
34. Nakamura M., Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. European Journal of Pharmacology. 135:1987;145-153
35. North R.A., Egan T.M. Actions and distribution of opioid peptides in peripheral tissues. British Medical Bulletin. 39:1983;71-75
36. Nozaki-Taguchi N., Yamamoto T. Involvement of nitric oxide in peripheral antinociception mediated by κ and δ-opioid receptors. Anesthesia and Analgesia. 87:1998;388-393
37. Picolo G., Cassola A.C., Cury Y. Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom. European Journal of Pharmacology. 469:2003;57-64
38. Picolo G., Giorgi R., Cury Y. δ- Opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. European Journal of Pharmacology. 391:2000;55-62
39. Poole S., Lorenzetti B.B., Cunha J.M., Cunha F.Q., Ferreira S.H. Bradykinin B1 and B2 receptors, tumor necrosis factor alpha and inflammatory hyperalgesia. British Journal of Pharmacology. 126:1999;649-656
40. Przewlocha R., Machelska H., Przewlocka B. Involvement of the nitric oxide pathway in nociceptive processes in the central nervous system in rats. Regulatory Peptides. 1:1994;S75-S76
41. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflammed tissue. Archives Internationales de Pharmacodynamie et de Therapie. 111:1957;209-219
42. Salvemini D., Wang Z.Q., Wyatt P.S., Bourdon D.M., Marino M.H., Manning P.T., Currie M.G. Nitric oxide: a key mediator in the early and late phase of carrageenin-induced rat paw inflammation. British Journal of Pharmacology. 118:1996;829-838
43. 2-induced cAMP production and sensitization of sensory neurons. Journal of Biological Chemistry. 276:2001;16083-16091
44. Stein C. Peripheral mechanisms of opioid analgesy. Anesth Analg. 76:1993;182-191
45. Stein C., Hassan A.H.S., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proceedings of the National Academy of Sciences (USA). 87:1990;5935-5939
46. Stein C., Milln M.J., Shippenberg T.S., Herz A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neuroscience Letters. 84:1988;225-228
47. Stein C., Milln M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Journal of Pharmacology and Experimental Therapeuthics. 248:1989;1269-1275
48. Taiwo Y.O., Levine J.D. Further confirmation of the role of adenylyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 44:1991;131-135
49. Tischler A.S., DeLellis R.A., Slayton V.W., Blount M.W., Wolfe H.J. Enkephalin-like immunoreactivity in human adrenal medullary cultures. Laboratory Investigation. 48:1983;13-18
50. Truong W., Cheng C., Xu Q.G., Li X.Q., Zochodne D.W. Mu opioid receptors and analgesia at a site of a peripheral nerve injury. Annals of Neurology. 53:2003;366-375
51. Vital-Brazil O. Neurotoxins from South American rattlesnake. Journal of Formosan Medical Association. 71:1972;394-396
52. White R.E. Cyclic GMP and ion channel regulation. Advances in Second Messenger Phosphoprotein Research. 33:1999;251-277
53. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110